Preview

The Russian Archives of Internal Medicine

Advanced search

Systemic inflammation and complications of”vascular" comorbidity in patients with COPD

https://doi.org/10.20514/2226-6704-2015-0-5-17

Abstract

In this article the authors examine the chronic obstructive pulmonary disease (COPD) from the standpoint of comorbidity — in close connection with other common diseases of modern social comorbid patient. This article presents the known and suspected, confirmed and studied basic mechanisms of the pathogenesis of COPD and a number of systemic diseases. Typical pathological process, which the authors explain the stages of formation of comorbidity is a chronic systemic inflammation. On the pages of this paper reviewed the most famous today inflammatory markers and a causal connection with the increase of their concentration and worsening destabilization of these disease entities and clinical conditions such as coronary heart disease, hypertension, diabetes, obesity, atrial fibrillation, stroke, osteoporosis and malignant neoplasm.

About the Authors

A. S. Skotnikov
I.M. Sechenov First Moscow State Medical University
Russian Federation

Department of emergency conditions in the clinic of internal diseases of the Institute of Professional Education,

Moscow



O. M. Dokhova
Polyclinic № 6 of Department of Health of Moscow
Russian Federation
Moscow


E. S. Shulgina
Children's Clinical Hospital № 9 of Khabarovsk
Russian Federation
Khabarovsk


References

1. Global Strategy for Diagnosis, Management, and Prevention of COPD. Updated January 2014.

2. Dvoretckiy L.I. Anemia in patients with chronic obstructive pulmonary disease: comorbidity or systemic manifestation? Pulmonologia. 2012; 2: 5-11.

3. Ovcharenko S.I. To the question about the diagnosis of COPD. Consilium medicum. 2014; 12: 17-26.

4. Apkhipov V.V. Chronic obstructive pulmonary disease and chronic heart failure: features of the combination therapy. Pulmonologia. 2010; 6: 120-126.

5. Gaynitdinova V.V., Avdeev S.N. Remodeling of large peripheral arteries in patients with chronic obstructive pulmonary disease and when it is combined with hypertension. Pulmonologia. 2015; 1: 50-57.

6. Morgunov L.U. Hypogonadism and chronic obstructive pulmonary disease. Vrach skoroj pomoshi. 2015; 5: 36-45.

7. Sinopalnikov A.I. New in the pharmacotherapy of chronic obstructive pulmonary disease - prevention of exacerbations of the disease (focus on roflumilast). Klinicheskaya medicina. 2014; 2: 57-64.

8. Chuchalin A.G., Tceimakh I.Y., Momot A.P., Mamaev A.N., Karbishev I.A., Kostuchenko G.I. Changes in systemic inflammatory and hemostatic responses in patients with acute exacerbation of chronic obstructive pulmonary disease associated with chronic heart failure and obesity. Pulmonologia. 2014; 6: 25-32.


Review

For citations:


Skotnikov A.S., Dokhova O.M., Shulgina E.S. Systemic inflammation and complications of”vascular" comorbidity in patients with COPD. The Russian Archives of Internal Medicine. 2015;(5):49-54. (In Russ.) https://doi.org/10.20514/2226-6704-2015-0-5-17

Views: 1135


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2226-6704 (Print)
ISSN 2411-6564 (Online)